Cancer chemopreventive activity and bioavailability of tea and tea polyphenols

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 523-524, Issue , 2003, Pages 201-208

  Lambert, Joshua D ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Bioavailability; Cancer chemoprevention; Catechin; Polyphenols; Tea

Indexed keywords

BLACK TEA EXTRACT; CAMELLIA SINENSIS EXTRACT; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER; CANCER PREVENTION; CELL LINE; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG TRANSFORMATION; DRUG USE; HUMAN; LIFESTYLE; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CAMELLIA; CAMELLIA SINENSIS;

EID: 0042454749     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00336-6     Document Type: Conference Paper

References (54)

1. D. Balentine, Manufacture and chemistry of tea, in: M. Huang, C.T. Ho, C. Lee (Eds.), Phenolic Compounds in Food and their Effects on Health, ACS, Washington, DC, 1992, pp. 103-117.
2. Yang C.S., Maliakal P., Meng X. Inhibition of carcinogenesis by tea. Ann. Rev. Pharmacol. Toxicol. 42:2001;25-54.
3. Caderni G., De Filippo C., Luceri C., Salvadori M., Giannini A., Biggeri A., Remy S., Cheynier V., Dolara P. Effects of black tea, green tea, and wine extracts on intestinal carcinogenesis induce by azoxymethane in F344 rats. Carcinogenesis. 21:2000;1965-1969.
4. Cao J., Xu Y., Chen J., Klaunig J. Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam. Appl. Toxicol. 29:1996;244-250.
5. Chung F.-L., Yang M., Rivenson A., Iatropoulos M., Reinhardt J., Pittman B., Ho C.-T., Amin S. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res. 58:1998;4096-4101.
6. Landau J., Wang Z.-Y., Yang G.-Y., Ding W., Yang C.S. Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis. 19:1998;501-507.
7. Lou Y.-R., Lu Y.-P., Xie J.-G., Huang M.-T., Conney A.H. Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH1 mice previously treated with ultraviolet B light. Nutr. Cancer. 33:1999;146-153.
8. Majima T., Tsutsumi M., Nishino H., Tsunoda T., Konishi Y. Inhibitory effects of beta-carotene, palm carotene, and green tea polyphenolson pancreatic carcinogenesis initiated by by N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters. Pancreas. 16:1998;13-18.
9. Suganuma M., Ohkura Y., Okabe S., Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in min mice. Jpn. Cancer Res. Clin. Oncol. 127:2001;69-72.
10. Weisburger J., Rivenson A., Garr K., Aliaga C. Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett. 114:1997;323-327.
11. Yang C.S., Wang Z.-Y. Tea and cancer. J. Natl. Cancer Inst. 85:1997;1038-1049.
12. Yang G.-Y., Liu Z., Seril D.N., Liao J., Ding W., Lim S., Bondoc F., Yang C.S. Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Carcinogenesis. 18:1997;2361-2365.
13. Huang M.T., Xie J., Wang Z., Ho C.T., Lou Y., Wang C., Hard G., Conney A.H. Effects of tea, decaffeinated tea, and caffeine on UVB-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res. 57:1997;2623-2629.
14. Tsubono Y., Nishino Y., Komatsu S., Hsieh C.-C., Kanemura S., Tsuji I., Nakatsuka H., Fukao A., Satoh H., Hisamichi S. Green tea and the risk of gastric cancer in Japan. New Engl. J. Med. 344:2001;632-636.
15. Gao Y., McLaughlin J., Blot W., Ji B., Dai Q., Fraumeni J. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl Cancer Inst. 86:1994;855-858.
16. Z.Y. Wang, L. Chen, M.-J. Lee, C.S. Yang. Tea and cancer prevention, in: J. Finley, D. Armstrong, S. Nagy, S. Robinson (Eds.), Hypernutritious Foods, AGSCIENCE Inc., Auburndale, FL, 1996, pp. 239-259.
17. Goldbohm R., Hertog M., Brants H., van Poppel G., van den Brandt P. Consumption of black tea and cancer risk: a prospective cohort study. J. Natl. Cancer Inst. 88:1996;93-100.
18. Su L., Arab L. Tea consumption and the reduced risk of colon cancer; results from a national prospective cohort study. Proc. Am. Assoc. Cancer Res. 41:2000;5141.
19. Chung L., Cheung T., Kong S., Fung K., Choy Y., Chan Z., Kwok T. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 68:2001;1207-1214.
20. M. Lea, Q. Xiao, A. Sadhukhan, S. Cottle, Z.-Y. Wang, C.S. Yang, Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells, Cancer Lett. 68 (1993) 231-236.
21. Uesato S., Kitagawa Y., Kamishimoto M., Kumagai A., Hori H., Nagasawa H. Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Cancer Lett. 170:2001;41-44.
22. Yang G.-Y., Liao J., Kim K., Yurkow E., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:1998;611-616.
23. Lu Y.-P., Lou Y.-R., Xie J.-G., Yen P., Huang M.-T., Conney A.H. Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA. Carcinogenesis. 18:1997;2163-2169.
24. Huang M.-T., Ho C.-T., Wang Z.-Y., Ferraro T., Finnegan-Olive T., Lou Y.R., Mitchel J.M., Laskin J.D., Newmark H., Yang C.S. Inhibitory effect of topical application of green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis. 13:1992;947-954.
25. Xu Y., Ho C.-T., Amin S., Han C., Chung F.-L. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52:1992;3875-3879.
26. Ahmad N., Cheng P., Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocetachin-3-gallate. Biochem. Biophys. Res. Commun. 275:2000;328-334.
27. Liang Y., Lin-Shiau S., Chen C., Lin J. Inhibition of cyclin-dependentkinases 2 and 4 as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin gallate. J. Cell. Biochem. 75:1999;1-12.
28. Liberto M., Cobrinik D. Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate. Cancer Lett. 154:2000;151-161.
29. Gupta S., Ahmad N., Nieminen A.-L., Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 164:2000;82-90.
30. Chung J., Park J., Phyu H., Dong Z., Yang C.S. Mechanisms of inhibition of the ras-MAP kinase pathway in 30.7b ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J. 15:2001;2022-2024.
31. 2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis. 21:2000;2035-2039.
32. Ahmad N., Gupta S., Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch. Biochem. Biophys. 376:2000;338-346.
33. Liang Y.-C., Lin-Shiau S.-Y., Chen D.-F., Lin J.-K. Suppresion of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell. Biochem. 67:1997;55-65.
34. Chen W., Dong Z., Valcic S., Timmermann B.N., Bowden G.T. Inhibition of ultraviolet-B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol. Carcinog. 24:1999;79-84.
35. Hayakawa S., Saeki K., Sazuka M., Suzuki Y., Shoji Y., Ohta T., Kaji K., Yuo A., Isemura M. Apoptosis induction by epicatechin gallate involves its binding to FAS. Biochem. Biophys. Res. Commun. 285:2001;1102-1106.
36. Berger S., Gupta S., Belfi C., Gosky D., Mukhtar H. Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem. Biophys. Res. Commun. 288:2001;101-105.
37. Piskula M., Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugating enzymes in rat tissue. J. Nutr. 128:1998;1172-1178.
38. Terao J. Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidant defense in blood plasma. J. Med. Invest. 46:1999;159-168.
39. Okushio K., Suzuki M., Matsumoto N., Nanjo F., Hara Y. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat. Drug Metabol. Disp. 27:1999;309-316.
40. Okushio K., Suzuki M., Matsumoto N., Nanjo F., Hara Y. Methylation of tea catechins by rat liver homogenates. Biosci. Biotech. Biochem. 63:1999;430-432.
41. Kida K., Suzuki M., Matsumoto N., Nanjo F., Hara Y. Identification of biliary metabolites of (-)-epigallocatechin gallate in rats. J. Agric. Food Chem. 48:2000;4151-4155.
42. Lee M.-J., Wang Z.-Y., Li H., Chen L., Sun Y., Gobbo S., Balentine D., Yang C.S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4:1995;393-399.
43. Chow H.H.S., Cai Y., Alberts D.S., Hakim I., Dorr R.T., Shahi F., Crowell J., Yang C.S., Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and Polyphenon E. Cancer Epidemiol. Biomarkers Prev. 10:2001;53-58.
44. Li C., Lee M.-J., Sheng S., Meng X., Prabhu S., Winnik B., Huang B., Chung J., Yan S., Ho C.-T., Yang C.S. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea consumption. Chem. Res. Toxicol. 13:2000;177-184.
45. Meselhy M., Nakamura N., Hattori M. Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria. Chem. Pharm. Bull. 45:1997;888-893.
46. Chen L., Lee M.-J., Li H., Yang C.S. Absorption, distribution, and elimination of tea polphenols in rats. Drug Metabol. Disp. 9:1997;1045-1050.
47. Nakagawa K., Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. Nutr. Sci. Vitaminol. 43:1997;679-684.
48. 3H ](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue Carcinogenesis. 19:1998;1771-1776.
49. Kohri T., Nanjo F., Suzuki M., Seto R., Matsumoto N., Yamakawa M., Hojo H., Hara Y., Desai D., Amin S., Conaway C., Chung F.-L. Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J. Agric. Food Chem. 49:2001;1042-1048.
50. Kim S., Lee M.-J., Hong J., Li C., Smith T., Yang G.-Y., Seril D., Yang C.S. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer. 37:2000;41-48.
51. Yang C., Chen L., Lee M.-J., Balentine D., Kuo M., Schantz S. Blood and urine levels of tea catechinsafter ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7:1998;351-354.
52. Mulder T., van Platerink C., Schuyl P., va Amelsvoort J. Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B. 760:2001;271-279.
53. Lipinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25.
54. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. Part 1. Prediction of intestinal absorption. J. Pharm. Sci. 88:1999;807-814.